1.           Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1         US and Europe Gene Editing Market– By Technology

1.3.2         US and Europe Gene Editing Market– By Products and Services

1.3.3         US and Europe Gene Editing Market– By Application

1.3.4         US and Europe Gene Editing Market– By End User

1.3.5         Gene Editing Market– By Geography

2.           Executive Summary

3.       Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           US and Europe Gene Editing Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1         US – PEST Analysis

4.2.2         Europe – PEST Analysis

4.3       Expert Opinions

5.           Gene Editing Market – Key Market Dynamics

5.1       Market Drivers

5.1.1         Rise in Prevalence of Cancer and Other Genetic Disorders

5.1.2         Continuous Technological Advancements in Gene Editing Tools

5.2       Market Restraints

5.2.1         High Cost of Production of Gene Editing Methods

5.3       Market Opportunities

5.3.1         Growing Biotechnology Industry in US and Europe

5.4       Future Trends

5.4.1         Strategic Initiatives by Market Players to Develop New Products

5.5       Impact Analysis

6.           Gene Editing Market – US and Europe Analysis

6.1       US and Europe Gene Editing Market Revenue Forecast and Analysis

6.2       Market Positioning of Key Players

7.           US and Europe Gene Editing Market Analysis –  By Technology

7.1       Overview

7.1.1         US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)

7.2       CRISPR

7.2.1         Overview

7.2.2         US and Europe CRISPR Market Revenue and Forecasts to 2030 (US$ Million)

7.3       TALEN

7.3.1         Overview

7.3.2         US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)

7.4       Antisense

7.4.1         Overview

7.4.2         US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)

7.5       Zinc Finger Nucleases (ZFNs)

7.5.1         Overview

7.5.2         US and Europe Zinc Finger Nucleases (ZFNs)Market Revenue and Forecasts to 2030 (US$ Million)

7.6       Others

7.6.1         Overview

7.6.2         US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

8.           US and Europe Gene Editing Market Analysis – By Products and Services

8.1       Overview

8.1.1         US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)

8.2       Reagents and Consumables

8.2.1         Overview

8.2.2         US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)

8.3       Instruments

8.3.1         Overview

8.3.2         US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)

8.4       Others

8.4.1         Overview

8.4.2         US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

9.           US and Europe Gene Editing Market Analysis –  By Application

9.1       Overview

9.1.1         US and Europe Gene Editing Market, By Application 2022 & 2030 (%)

9.2       Cell Line Engineering

9.2.1         Overview

9.2.2         US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)

9.3       Genetic Engineering

9.3.1         Overview

9.3.2         US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)

9.4       Diagnostic Application

9.4.1         Overview

9.4.2         US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)

9.5       Drug Discovery

9.5.1         Overview

9.5.2         US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)

9.6       Others

9.6.1         Overview

9.6.2         US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

10.        US and Europe Gene Editing Market Analysis –  By End User

10.1     Overview

10.1.1       US and Europe Gene Editing Market, By End User 2022 & 2030 (%)

10.2     Pharmaceutical & Biotechnology Companies

10.2.1       Overview

10.2.2       US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)

10.3     Academic and Research Institutes

10.3.1       Overview

10.3.2       US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)

10.4     Contract Research Organization (CROs)

10.4.1       Overview

10.4.2       US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030  (US$ Million)

10.5     Others

10.5.1       Overview

10.5.2       US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

11.        US and Europe Gene Editing Market Analysis

11.1     US Gene Editing Market Revenue Forecast and Analysis

11.1.1       Overview

11.1.2       US: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)

11.1.3       US: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)

11.1.4       US: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)

11.1.5       US: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)

11.1.6       US: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

11.2     Europe Gene Editing Market Revenue Forecast and Analysis

11.2.1       Overview

11.2.2       Europe: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)

11.2.3       Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)

11.2.4       Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)

11.2.5       Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)

11.2.6       Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

11.2.7       Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Country (%)

11.2.8       Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.8.1          Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.8.2          Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)

11.2.8.3          Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)

11.2.8.4          Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)

11.2.8.5          Germany: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

11.2.9       UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.9.1          UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.9.2          UK: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)

11.2.9.3          UK: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)

11.2.9.4          UK: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)

11.2.9.5          UK: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

11.2.10    France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.10.1       France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.10.2       France: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)

11.2.10.3       France: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)

11.2.10.4       France: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)

11.2.10.5       France: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

11.2.11    Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.11.1       Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.11.2       Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)

11.2.11.3       Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)

11.2.11.4       Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)

11.2.11.5       Italy: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

11.2.12    Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.12.1       Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.12.2       Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)

11.2.12.3       Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)

11.2.12.4       Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)

11.2.12.5       Spain: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

11.2.13    Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.13.1       Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

11.2.13.2       Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)

11.2.13.3       Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)

11.2.13.4       Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)

11.2.13.5       Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

12.        Industry Landscape

12.1     Overview

12.2     Growth Strategies in US and Europe Gene Editing Market

12.3     Organic Growth Strategies

12.3.1       Overview

12.4     Inorganic Growth Strategies

12.4.1       Overview

13.        Company Profiles

13.1     Thermo Fisher Scientific Inc

13.1.1       Key Facts

13.1.2       Business Description

13.1.3       Products and Services

13.1.4       Financial Overview

13.1.5       SWOT Analysis

13.1.6       Key Developments

13.2     Merck KGaA

13.2.1       Key Facts

13.2.2       Business Description

13.2.3       Products and Services

13.2.4       Financial Overview

13.2.5       SWOT Analysis

13.2.6       Key Developments

13.3     Lonza Group AG

13.3.1       Key Facts

13.3.2       Business Description

13.3.3       Products and Services

13.3.4       Financial Overview

13.3.5       SWOT Analysis

13.3.6       Key Developments

13.4     Horizon Discovery Group plc.

13.4.1       Key Facts

13.4.2       Business Description

13.4.3       Products and Services

13.4.4       Financial Overview

13.4.5       SWOT Analysis

13.4.6       Key Developments

13.5     Integrated DNA Technologies, Inc.

13.5.1       Key Facts

13.5.2       Business Description

13.5.3       Products and Services

13.5.4       Financial Overview

13.5.5       SWOT Analysis

13.5.6       Key Developments

13.6     GenScript Biotech Corporation

13.6.1       Key Facts

13.6.2       Business Description

13.6.3       Products and Services

13.6.4       Financial Overview

13.6.5       SWOT Analysis

13.6.6       Key Developments

13.7     New England Biolabs

13.7.1       Key Facts

13.7.2       Business Description

13.7.3       Products and Services

13.7.4       Financial Overview

13.7.5       SWOT Analysis

13.7.6       Key Developments

13.8     Eurofins Scientific SE

13.8.1       Key Facts

13.8.2       Business Description

13.8.3       Products and Services

13.8.4       Financial Overview

13.8.5       SWOT Analysis

13.8.6       Key Developments

13.9     CRISPR Therapeutics

13.9.1       Key Facts

13.9.2       Business Description

13.9.3       Products and Services

13.9.4       Financial Overview

13.9.5       SWOT Analysis

13.9.6       Key Developments

13.10  Editas Medicine Inc

13.10.1    Key Facts

13.10.2    Business Description

13.10.3    Products and Services

13.10.4    Financial Overview

13.10.5    SWOT Analysis

13.10.6    Key Developments

13.11  ElevateBio LLC

13.11.1    Key Facts

13.11.2    Business Description

13.11.3    Products and Services

13.11.4    Financial Overview

13.11.5    SWOT Analysis

13.11.6    Key Developments

14.        Appendix

14.1     Glossary of Terms

LIST OF TABLES

Table 1.             US: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)

Table 2.             US: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)

Table 3.             US: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)

Table 4.             US: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)

Table 5.             Europe: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)

Table 6.             Europe: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)

Table 7.             Europe: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)

Table 8.             Europe: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)

Table 9.             Germany: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)

Table 10.          Germany: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)

Table 11.          Germany: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)

Table 12.          Germany: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)

Table 13.          UK: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)

Table 14.          UK: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)

Table 15.          UK: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)

Table 16.          UK: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)

Table 17.          France: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)

Table 18.          France: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)

Table 19.          France: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)

Table 20.          France: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)

Table 21.          Italy: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)

Table 22.          Italy: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)

Table 23.          Italy: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)

Table 24.          Italy: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)

Table 25.          Spain: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)

Table 26.          Spain: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)

Table 27.          Spain: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)

Table 28.          Spain: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)

Table 29.          Rest of Europe: Gene Editing Market, By Technology – Revenue and Forecast to 2030 (USD Million)

Table 30.          Rest of Europe: Gene Editing Market, By Products and Services – Revenue and Forecast to 2030 (USD Million)

Table 31.          Rest of Europe: Gene Editing Market, By Application– Revenue and Forecast to 2030 (USD Million)

Table 32.          Rest of Europe: Gene Editing Market, By End User– Revenue and Forecast to 2030 (USD Million)

Table 33.          Recent Organic Growth Strategies in US and Europe Gene Editing Market

Table 34.          Recent Inorganic Growth Strategies in the US and Europe Gene Editing Market

Table 35.          Glossary of Terms, Gene Editing Market

LIST OF FIGURES

Figure 1.           Gene Editing Market Segmentation

Figure 2.           Gene Editing Market Segmentation, by Region

Figure 3.           US and Europe Gene Editing Market Overview

Figure 4.           CRISPR Segment Held Largest Share of Gene Editing Market

Figure 5.           UK to Show Significant Growth During Forecast Period

Figure 6.           US and Europe Gene Editing Market – Leading Country Markets (US$ Million)

Figure 7.           US and Europe Gene Editing Market, Industry Landscape

Figure 8.           US PEST Analysis

Figure 9.           Europe PEST Analysis

Figure 10.        Gene Editing Market – Key Industry Dynamics

Figure 11.        Gene Editing Market Impact Analysis of Drivers and Restraints

Figure 12.        US and Europe Gene Editing Market – Revenue Forecast and Analysis – 2020–2030

Figure 13.        Market Positioning of Key Players in US and Europe Gene Editing Market

Figure 14.        US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)

Figure 15.        US and Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2030 (US$ Million)

Figure 16.        US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)

Figure 17.        US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)

Figure 18.        US and Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2030 (US$ Million)

Figure 19.        US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

Figure 20.        US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)

Figure 21.        US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)

Figure 22.        US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)

Figure 23.        US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

Figure 24.        US and Europe Gene Editing Market, By Application 2022 & 2030 (%)

Figure 25.        US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)

Figure 26.        US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)

Figure 27.        US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)

Figure 28.        US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)

Figure 29.        US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

Figure 30.        US and Europe Gene Editing Market, By End User 2022 & 2030 (%)

Figure 31.        US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)

Figure 32.        US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)

Figure 33.        US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)

Figure 34.        US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

Figure 35.        US Gene Editing Market– Revenue Forecast and Analysis – 2020- 2030

Figure 36.        Europe Gene Editing Market– Revenue Forecast and Analysis – 2020- 2030

Figure 37.        Europe: Gene Editing Market -Revenue and Forecasts to 2030, By Country (%)

Figure 38.        Germany: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

Figure 39.        UK: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

Figure 40.        France: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

Figure 41.        Italy: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

Figure 42.        Spain: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

Figure 43.        Rest of Europe: Gene Editing Market – Revenue and Forecast to 2030 (USD Million)

Figure 44.        Growth Strategies in US and Europe Gene Editing Market